Specific deficits in visual electrophysiology in a mouse model of dominant optic atrophy

Experimental Eye Research

Volumn 93, Issue 5, 2011, Pages 771-777

  Barnard, Alun R ^a   Issa, Peter Charbel ^a   Perganta, Georgia ^a   Williams, Pete A ^b   Davies, Vanessa J ^b   Sekaran, Sumathi ^a   Votruba, Marcela ^b,c   MacLaren, Robert E ^a,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Electrophysiology; ERG; Ganglion cell; Opa1; Optic atrophy; Retina; VEP

Indexed keywords

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT OPTIC ATROPHY; CONTROLLED STUDY; CORRELATIONAL STUDY; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; FEMALE; LIGHT ADAPTATION; MALE; MOUSE; MUTANT; NERVE CELL; NONHUMAN; PHENOTYPE; PHOTOPIC VISION; PRIORITY JOURNAL; SENSORY SYSTEM ELECTROPHYSIOLOGY; WILD TYPE;

ANIMALS; DARK ADAPTATION; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; EVOKED POTENTIALS, VISUAL; GTP PHOSPHOHYDROLASES; MICE; MICE, INBRED C57BL; OPTIC ATROPHY, AUTOSOMAL DOMINANT; PHOTIC STIMULATION; RETINA; RETINAL GANGLION CELLS; VISION DISORDERS;

EID: 81355147506     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.07.004     Document Type: Article

References (34)

1. Aijaz S., Erskine L., Jeffery G., Bhattacharya S.S., Votruba M. Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer. Invest. Ophthalmol. Vis. Sci. 2004, 45:1667-1673.
2. Alarcon-Martinez L., Aviles-Trigueros M., Galindo-Romero C., Valiente-Soriano J., Agudo-Barriuso M., Villa Pde L., Villegas-Perez M.P., Vidal-Sanz M. ERG changes in albino and pigmented mice after optic nerve transection. Vision Res. 2010, 50:2176-2187.
3. Alarcon-Martinez L., de la Villa P., Aviles-Trigueros M., Blanco R., Villegas-Perez M.P., Vidal-Sanz M. Short and long term axotomy-induced ERG changes in albino and pigmented rats. Mol. Vis. 2009, 15:2373-2383.
4. Alexander C., Votruba M., Pesch U.E., Thiselton D.L., Mayer S., Moore A., Rodriguez M., Kellner U., Leo-Kottler B., Auburger G., Bhattacharya S.S., Wissinger B. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 2000, 26:211-215.
5. Amati-Bonneau P., Milea D., Bonneau D., Chevrollier A., Ferre M., Guillet V., Gueguen N., Loiseau D., de Crescenzo M.A., Verny C., Procaccio V., Lenaers G., Reynier P. OPA1-associated disorders: phenotypes and pathophysiology. Int. J. Biochem. Cell Biol. 2009, 41:1855-1865.
6. Barnard A.R., Hattar S., Hankins M.W., Lucas R.J. Melanopsin regulates visual processing in the mouse retina. Curr. Biol. 2006, 16:389-395.
7. Berninger T.A., Jaeger W., Krastel H. Electrophysiology and colour perimetry in dominant infantile optic atrophy. Br. J. Ophthalmol. 1991, 75:49-52.
8. Bette S., Schlaszus H., Wissinger B., Meyermann R., Mittelbronn M. OPA1, associated with autosomal dominant optic atrophy, is widely expressed in the human brain. Acta Neuropathol. 2005, 109:393-399.
9. Bui B.V., Fortune B. Ganglion cell contributions to the rat full-field electroretinogram. J. Physiol. 2004, 555:153-173.
10. Davies V., Votruba M. Focus on molecules: the OPA1 protein. Exp. Eye Res. 2006, 83:1003-1004.
11. Davies V.J., Hollins A.J., Piechota M.J., Yip W., Davies J.R., White K.E., Nicols P.P., Boulton M.E., Votruba M. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum. Mol. Genet. 2007, 16:1307-1318.
12. Drasdo N., Aldebasi Y.H., Chiti Z., Mortlock K.E., Morgan J.E., North R.V. The s-cone PHNR and pattern ERG in primary open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2001, 42:1266-1272.
13. Granse L., Bergstrand I., Thiselton D., Ponjavic V., Heijl A., Votruba M., Andreasson S. Electrophysiology and ocular blood flow in a family with dominant optic nerve atrophy and a mutation in the OPA1 gene. Ophthalmic Genet. 2003, 24:233-245.
14. Heiduschka P., Schnichels S., Fuhrmann N., Hofmeister S., Schraermeyer U., Wissinger B., Alavi M.V. Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy. Invest. Ophthalmol. Vis. Sci. 2010, 51:1424-1431.
15. Holder G.E., Votruba M., Carter A.C., Bhattacharya S.S., Fitzke F.W., Moore A.T. Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter. Doc. Ophthalmol. 1998, 95:217-228.
16. Lachapelle J., Ouimet C., Bach M., Ptito A., McKerral M. Texture segregation in traumatic brain injury - a VEP study. Vision Res. 2004, 44:2835-2842.
17. Li B., Barnes G.E., Holt W.F. The decline of the photopic negative response (PhNR) in the rat after optic nerve transection. Doc. Ophthalmol. 2005, 111:23-31.
18. Luhmann U.F., Robbie S., Munro P.M., Barker S.E., Duran Y., Luong V., Fitzke F.W., Bainbridge J.W., Ali R.R., MacLaren R.E. The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest. Ophthalmol. Vis. Sci. 2009, 50:5934-5943.
19. Miura G., Wang M.H., Ivers K.M., Frishman L.J. Retinal pathway origins of the pattern ERG of the mouse. Exp. Eye Res. 2009, 89:49-62.
20. Miyata K., Nakamura M., Kondo M., Lin J., Ueno S., Miyake Y., Terasaki H. Reduction of oscillatory potentials and photopic negative response in patients with autosomal dominant optic atrophy with OPA1 mutations. Invest. Ophthalmol. Vis. Sci. 2007, 48:820-824.
21. Mojumder D.K., Sherry D.M., Frishman L.J. Contribution of voltage-gated sodium channels to the b-wave of the mammalian flash electroretinogram. J. Physiol. 2008, 586:2551-2580.
22. Moshiri A., Gonzalez E., Tagawa K., Maeda H., Wang M., Frishman L.J., Wang S.W. Near complete loss of retinal ganglion cells in the math5/brn3b double knockout elicits severe reductions of other cell types during retinal development. Dev. Biol. 2008, 316:214-227.
23. North R.V., Jones A.L., Drasdo N., Wild J.M., Morgan J.E. Electrophysiological evidence of early functional damage in glaucoma and ocular hypertension. Invest. Ophthalmol. Vis. Sci. 2010, 51:1216-1222.
24. Porciatti V. The mouse pattern electroretinogram. Doc. Ophthalmol. 2007, 115:145-153.
25. Sagdullaev B.T., DeMarco P.J., McCall M.A. Improved contact lens electrode for corneal ERG recordings in mice. Doc. Ophthalmol. 2004, 108:181-184.
26. Saszik S.M., Robson J.G., Frishman L.J. The scotopic threshold response of the dark-adapted electroretinogram of the mouse. J. Physiol. 2002, 543:899-916.
27. Viswanathan S., Frishman L.J., Robson J.G. The uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity. Invest. Ophthalmol. Vis. Sci. 2000, 41:2797-2810.
28. Votruba M. Molecular genetic basis of primary inherited optic neuropathies. Eye (Lond) 2004, 18:1126-1132.
29. Votruba M., Fitzke F.W., Holder G.E., Carter A., Bhattacharya S.S., Moore A.T. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch. Ophthalmol. 1998, 116:351-358.
30. White K.E., Davies V.J., Hogan V.E., Piechota M.J., Nichols P.P., Turnbull D.M., Votruba M. OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy. Invest. Ophthalmol. Vis. Sci. 2009, 50:2567-2571.
31. Williams P.A., Morgan J.E., Votruba M. Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. Brain 2010, 133:2942-2951.
32. Xu H., Chen M., Manivannan A., Lois N., Forrester J.V. Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 2008, 7:58-68.
33. Yin L., Greenberg K., Hunter J.J., Dalkara D., Kolstad K.D., Masella B.D., Wolfe R., Visel M., Stone D., Libby R.T., Diloreto D., Schaffer D., Flannery J., Williams D.R., Merigan W.H. Intravitreal injection of AAV2 transduces macaque inner retina. Invest. Ophthalmol. Vis. Sci 2011.
34. Yu-Wai-Man P., Griffiths P.G., Gorman G.S., Lourenco C.M., Wright A.F., Auer-Grumbach M., Toscano A., Musumeci O., Valentino M.L., Caporali L., Lamperti C., Tallaksen C.M., Duffey P., Miller J., Whittaker R.G., Baker M.R., Jackson M.J., Clarke M.P., Dhillon B., Czermin B., Stewart J.D., Hudson G., Reynier P., Bonneau D., Marques W., Lenaers G., McFarland R., Taylor R.W., Turnbull D.M., Votruba M., Zeviani M., Carelli V., Bindoff L.A., Horvath R., Amati-Bonneau P., Chinnery P.F. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010, 133:771-786.